Diagnosis and Treatment of Inhalant Allergies’

The Diagnosis and Treatment of Inhalant Allergies

The American Academy of Environmental Medicine designates this educational activity for a maximum of 14.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Allergic rhinitis plays a major role in the lives of millions of Americans.  Primary care physicians will see many patients with this disease or diseases that mimic it.  Physicians commonly prescribe medications for allergic rhinitis without knowing the inciting antigen or antigens.  Allergy testing can complete the picture for the physician and can play a role in the treatment strategies used to combat this disease.  Many physicians do not receive this training in residency, and allergy testing can be somewhat of a mystery.  Allergy testing plays a key role in immunotherapy, which is a viable alternative to medical management.  Skin prick testing remains the most used test because of its ease of use, and its rapid results.  It remains a great screening tool for allergic disease.  Intradermal testing is slightly more invasive and does not yield much more useful information.  In contrast, intradermal dilutional testing and modified quantitative testing are useful when a screening test is positive because they yield more information for starting doses of immunotherapy.  RAST is also an integral part of allergy testing when contraindications to skin/dermal testing exist.  There are still questions to be answered.

Treatment for allergies is big business!  In 2005, roughly 22 million Americans spent $11 billion on doctors’ bills, prescription drugs, and other medical care to relieve allergy symptoms, according to the Agency for Healthcare Research and Quality (AHRQ). Visits to doctors and hospitals accounted for $4 billion. The remaining roughly $7 billion was spent mostly on prescription drugs. Much of that expenditure could have been avoided if people had better access to effective immunotherapy.

This program has been designed for primary care providers, including physicians, nurses, physician assistants, and allergy technicians who participate in the treatment allergic rhinitis.   You and your allergy staff will learn with hands-on training the most effective diagnostic & immunotherapy modalities currently available for handling allergy problems found in all practices!  Use these techniques next week!

OBJECTIVES:

Upon the completion of this course, the participant should be able to:

v  On physical examination, recognize signs of allergies and sensitivities in various body systems.

v  Prescribe practical strategies to help patients in controlling environmental exposures.

v  Articulate an understanding of the basic immunology involved in inhalant immunotherapy.

v  Articulate how to prevent, recognize and treat an adverse or anaphylactic reaction.

v  Describe how to confirm clinical suspicions and determine the levels of sensitivity with quantitative intradermal testing for specific allergens.

v  Set up an allergy treatment plan and demonstrate how to prepare a patient’s antigen vial(s) for immunotherapy.

v  Discuss how to manage common difficulties in the administration of immunotherapy;

The American Academy of Environmental Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Date

Thursday-Friday, March 29-30, 2012